MegMan Performance Booster — Class I drug recall D-0557-2022
Terminated recall by Junp Hydration LLC, reported 2022-02-16, distributed nationwide. Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found
| Recall number | D-0557-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Junp Hydration LLC, Brooklyn, NY, United States |
| Recall initiated | 2022-02-04 |
| Classified | 2022-02-11 |
| Reported by FDA | 2022-02-16 |
| Terminated | 2022-06-09 |
| Distributed | Nationwide (US) |
| Quantity | 750 cartons |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 00848998000912 |
| Lot numbers | 2010291 |
| Expiration dates | 2024-01-07 |
Product
MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88
Reason for recall
Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0557-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.